genetically engineered cancer stem cell vaccine (University of Cincinnati)

N/A

Report date: 2025/01/26 15:38:41

Base Information

Drug Namegenetically engineered cancer stem cell vaccine (University of Cincinnati)
Drug Alias Namecancer stem cell vaccine (University of Cincinnati)
ClassificationVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptideCell and gene therapy > Cell therapy
Mechanisms of ActionInterleukin-15 receptors modulatorsInterleukin-15 receptors replacementInterleukin-15 receptors agonists
TargetsInterleukin-15 receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cincinnati
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Cincinnati
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A